AstraZeneca

Immunai, AstraZeneca collaborate to optimize cancer clinical trials

Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.

Cancer (Illustrative)
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

US to move COVID-19 vaccines, treatments to private markets in 2023

AION Labs CEO Mati Gil.

AION, aMoon up for top scientific innovation award

A health worker is seen preparing to administer the a third COVID-19 booster shot (illustrative).

COVID-19 booster shots are crucial, according to a Yale study


AstraZeneca to move local headquarters to O-TECH complex

AstraZeneca will lease 1,245 sq.m. in Building B in the O-TECH complex.

O-Tech complex

AstraZeneca resumes US COVID-19 vaccine trial as J&J prepares to do same

AstraZeneca paused its US trial on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial.

A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.

AstraZeneca resumes COVID-19 vaccine trial in Japan, US still paused

Trials in the UK, Brazil, South Africa and India had already restarted, but US trials remain paused.

A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.

AstraZeneca COVID-19 vaccine trial on hold after adverse patient reaction

The report said suspension of the trial was having an impact on other AstraZeneca vaccine trials - as well as on clinical trials being conducted by other vaccine makers.

The logo of AstraZeneca is seen on a medication package in a pharmacy in London April 28, 2014

Nine US, European COVID-19 vaccine developers sign pledge to uphold safety

Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines.

Bottles labeled "Vaccine" stand near medical syringe in front of "Coronavirus COVID-19" display (illustrative)

Emergent signs deal to make British COVID-19 vaccine

AstraZeneca in June picked Emergent to help produce 300 million doses of its potential COVID-19 vaccine pledged to the United States.

Scientists develop a vaccine against the coronavirus disease in Saint Petersburg

AstraZeneca signs $6 bln cancer drug deal with Daiichi

The London-listed company said on Monday it would pay Daiichi an upfront payment of $1 billion for DS-1062, a type of antibody drug conjugate (ADC).

The logo of AstraZeneca is seen on a medication package in a pharmacy in London April 28, 2014

Moderna, Merck will not limit price of COVID-19 vaccines to company cost

Executives from Johnson & Johnson and AstraZeneca testified that they will price their respective potential vaccines at no profit while the pandemic rages on.

Scientists develop a vaccine against the coronavirus disease in Saint Petersburg